PATIENT AI Act Discussion Draft, AMA Issue Brief for Clinical AI Liability Released
Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
1 min read
Audrey Ziegler Jan 28, 2025
The Centers for Medicare & Medicaid Services (CMS) has delayed the Clinical Laboratory Fee Schedule (CLFS) data reporting period and the phase-in of payment reductions for 2025 and made updates to tests subject to the reasonable charge payment.
Passage of section 221 of the Continuing Appropriations and Extensions Act of 2025 (H.R.9747) delayed data reporting requirements for clinical diagnostic laboratory tests (CDLTs) that are not advanced diagnostic laboratory tests (ADLTs). This legislation also delayed the phase-in of payment reductions under the CLFS from private payer rate implementation.
The changes, effective Jan. 1, 2025, included:
The minimum payment amount for 2025 is $18.19, a 2.4 percent increase from 2024, which is applicable for payments made on a reasonable charge basis according to the Consumer Price Index-Update. The affected codes for the national minimum payment amount are: 88142, 88143, 88147, 88148, 88150, 88152, 88153, 88164, 88165, 88166, 88167, 88174, 88175, G0123, G0143, G0144, G0145, G0147, G0148, Q0111, Q0115, and P3000.
The 2025 CLFS also includes separately payable fees for certain specimen collection methods (codes 36415, P9612, P9615, and G0471).
Sources:
https://www.cms.gov/files/document/mm13889-clinical-laboratory-fee-schedule-2025-annual-update.pdf
![]()
Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
Lincoln, NE – November 2026 TELCOR is proud to announce the promotion of Stephanie Gonnerman to Senior Analyst, Revenue Cycle Management (RCM).
The Centers for Medicare and Medicaid Services (CMS) released a report on Oct. 20 detailing significant differences in the share of reported test...